Skip to main content

Table 2 Patient Characteristics

From: A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix

Median Age, year-old (range) 50.5 (34–62)
Performance status, n (%)  
   0 13
   1 17
   2 0
FIGO stage  
   IIa2 3
   IIb 20
   IIIb 7
Histology  
 Squamous cell carcinoma 30
 Not Squamous cell carcinoma 0
Grade  
   NC* 5
   1 1
   2 20
   3 4
  1. *NC: not confirmed.